Bicara Therapeutics Inc Common Stock
Price & Volume
Stats
See moreOpen | $18.91 |
Previous Close | $19 |
Day Range | $18.39-$18.99 |
52W Range | $7.80-$22.67 |
Market Cap | $1B |
Shares Short | 7M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | $5.38 |
News
See moreYahoo Finance • 19 days ago
Bicara Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
Yahoo Finance • last month
ClearBridge Small Cap Strategy adds KWR, RNA, exits SEAT, GDRX among Q3 moves
Yahoo Finance • 2 months ago
Bicara Therapeutics Announces Ficerafusp Alfa Granted Breakthrough Therapy Designation by U.S. FDA for 1L HPV-Negative R/M HNSCC
Yahoo Finance • 2 months ago
Genmab reportedly nearing deal to acquire cancer drug developer Merus
About
CEO | Dr. Claire Mazumdar Clemon M.B.A., Ph.D. |
Address | 116 Huntington Avenue, Boston, MA, United States, 02116 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 55 |
